U.S. Senate Committee on Rules and Administration

11/19/2026 | Press release | Distributed by Public on 11/19/2026 14:28

Klobuchar, Colleagues Introduce Bipartisan Legislation to Support Families Facing Rare Childhood Disease

WASHINGTON - U.S. Senators Amy Klobuchar (D-MN), Roger Wicker (R-MS), Chris Coons (D-DE), and Eric Schmitt (R-MO) introduced the Genomic Answers for Children's Health Act of 2026. This bipartisan legislation would clarify that Medicaid must cover genomic sequencing for children with suspected rare diseases or genetic disorders who are enrolled in the program.

"For parents, few things are harder than knowing your child needs help and not having answers or knowing what options are available to help them. By expanding access to genomic sequencing for children with suspected rare diseases and genetic disorders, we can help parents get answers faster, doctors make more accurate diagnoses, and ensure families can get the care their children need," said Klobuchar. "This bipartisan bill is an important step toward improving health outcomes and saving children's lives."

"Parents of children with rare diseases often spend years waiting for a diagnosis. Even when test results arrive, the answers can be frustratingly inconclusive," said Wicker. "Genomic sequencing offers families faster and more reliable results. Through early detection, more patients will be able to get the care they need without endless delays and extensive testing, saving families and providers money in the long run."

"When your child is sick, there's nothing you wouldn't give to make them better," said Coons. "For millions of families across the nation whose children have a rare disease, they are left waiting and waiting for the answers and treatments they need. This bill brings an end to the waiting, giving families access to the keys that could unlock their children's futures."

"As the father of a child with a rare medical condition, I understand firsthand the challenges Missouri families like mine face," said Schmitt. "Worrying about the cost of care should be the last thing on a parent's mind. By ensuring Medicaid covers genomic sequencing for children with rare diseases, Missouri families will be able to better access the answers and care their children need."

Approximately 30 million Americans suffer from rare diseases, and half of these patients are children. For many, the diagnosis process can take between four to eight years, still yield inaccurate results, and amount to thousands of dollars in medical costs. Genomic sequencing - a type of testing that examines an individual's entire DNA sequence - is a more efficient way for kids to get accurate diagnoses earlier, while curative treatment still may be an option.

If signed into law, this bill would:

  • Require Medicaid to cover whole genome sequencing and whole exome sequencing as mandatory benefits for enrollees under the age of 21;
  • Direct states to expand access to genomic testing in hospital settings; and
  • Instruct the Secretary of Health and Human Services to raise awareness about genomic sequencing.

As Co-Chair of the Senate's Rare Disease Caucus, Senator Klobuchar has been a leader in strengthening medical research, the Food and Drug Administration's treatment review process, and expanding access to care for kids and adults living with rare health conditions.

The full text of the bill is available here.

###

U.S. Senate Committee on Rules and Administration published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 20:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]